Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]

” Earlier this month, a federal judge, appointed by President Donald Trump, reportedly rejected a similar line of argument when Christopher Quaglin, an alleged member of the Proud Boys who is accused of assaulting law enforcement officers on Jan. 6, sought pretrial release. [read post]